InvestorsHub Logo
Followers 17
Posts 676
Boards Moderated 0
Alias Born 12/30/2004

Re: None

Friday, 03/11/2016 1:31:13 PM

Friday, March 11, 2016 1:31:13 PM

Post# of 27643
This stock will be a lot higher or a lot lower in the next 3-4 weeks. The results of Two studies should or could be forthcoming in that period of time. HIV and Malaria are the only two things that the company can monetize at this time besides selling the company.
The market says this company is worth less than .02 a share, that must mean something but every once in awhile the market is very wrong. Most Mymetics studies and trials were performed by the company (or in China) and have not gotten much recognition to say the least. These two studies are a bit different and will make or break the company in my opinion. If the HIV study in Texas duplicates the study in China it should lead to the beginning of real Trials of a Mucosal Virosome based vaccine. The malaria study is a bit different being a new vaccine with ties to a larger study. Time will tell but there is not much time left.

If either one of these studies are a success be prepared for a good run in the stock. If they are both busts look for sub penny in the near term. This is just my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News